What We Do
...and Why We Do It.
“At Brain Matters Research, being a center of excellence carries a great responsibility. We are committed to compassionate care and support for the patient, family and caregivers, alike. We believe that state-of-the-art care includes informing patients and families about increased risk factors for the disease, the latest information on prevention, and about the different types of clinical trial opportunities currently available. At any given time, we typically have 18-20 ongoing trials. These trials range from prevention trials that seek to understand who gets this disease and why, to trials seeking to help current sufferers of Alzheimer’s or other dementias.
Our mission here at Brain Matters Research is to elevate Alzheimer’s Disease to the level of urgency that it deserves. It is a degenerative “cancer of the brain” that no one survives. Brain Matters Research is on a mission, and we need community involvement from those who have been diagnosed with Alzheimer’s, those at risk for the disease, those showing early symptoms of the disease, and those who are willing to participate in the research process. Doing nothing is no longer an option.”
Mark Brody MD, CPI
Founder, Principal Investigator
Brain Matters Research